Tumor Microenvironment Services
-
Manufactured by MedGenome Inc.based in USA
Profiling the Tumor Microenvironment: Using a genomics based approach to analyze the tumor microenvironment can provide unique insights beyond IHC and FACS methods. OncoPeptTUME deeply interrogates RNA-Seq data sets to produce high resolution mapping of the tumor microenvironment using ...
-
Manufactured by MedGenome Inc.based in USA
Detailed RNA specific QC reports. Differential expression analysis. Pathway enrichment analysis. Fusion and splicing event analysis with interactive genome browser to visualize results. Proprietary tumor microenvironment ...
-
Manufactured by Veracytebased in FRANCE
Leverage the widely used Nanostring platform to study gene expression in the tumor microenvironment, revealing biomarker signatures, mechanism of action, disease biology, and more. The most popular Nanostring service we offer is the nCounter® PanCancer IO 360™ Panel. This panel is designed to deliver immuno-oncology ...
-
Manufactured by Elpisciencebased in CHINA
bioinformatics with over 1,000 tumor organoid model collections that mimic the complex interaction between the human immune system and tumor ...
-
Manufactured by Immatics N.V.based in GERMANY
Immatics’ latest proprietary ACTengine® manufacturing processes are designed to generate cell product candidates within a short manufacturing window and deliver highly proliferative T cells, with the capability to infiltrate the patient’s tumor and function in a challenging solid tumor microenvironment. Immatics is ...
-
Manufactured by Veracytebased in FRANCE
Immunogram, Veracyte’s advanced analytics platform, integrates multi-omic data sets and analyzes them into a single per patient view of key biomarker signatures, specific to their own Tumor Microenvironment. This analytics platform delivers valuable insights to improve patient care and help clinical researchers make ...
-
by OracleBiobased in UNITED KINGDOM
Adding value to Immuno-Oncology studies with Quantitative Digital Pathology. Quantitative Digital Pathology provides deep insights into the tumor microenvironment (TME), a knowledge which is crucial for understanding the mechanism of action of new oncology immunotherapies or for investigating new biomarkers. ...
-
Manufactured by BiomXbased in ISRAEL
Our colorectal cancer program utilizes engineered phage with various payloads (such as immunostimulatory payloads) that are administered intravenously to target Fusobacterium nucleatum bacteria residing within the tumor microenvironment. The aim of payload delivery is to convert cold tumors to hot tumors with activated immune ...
-
Manufactured by Veracytebased in FRANCE
From our proprietary biomarkers, our innovated assays solutions, our unique data analysis platforms and our CDx development capabilities, we offer a comprehensive family of biomarker services that enhance your insight into the tumor microenvironment ...
-
based in GERMANY
Once a target is identified the various effects of the drug can be measured. This involves all read-outs we use during the biomarker validation but instead of looking at the effect of various candidates we focus on one component. As the tumor microenvironment can play an important role we focus especially on test methods involving fresh tissue. ...
-
based in GERMANY
, identify the different types of immune cells and their state of activation, as well as the role of the tumor microenvironment. ...
-
based in USA
Utilizing deep learning and advanced cell classification algorithms, multiplexed immunofluorescence spatial analysis uncovers the complex interplay between multitudes of immuno-oncology biomarkers and provides complete analysis of the tumor microenvironment. Multiplexed immunofluorescence has emerged as an effective and ...
-
based in USA
of anticancer T cells to overcome the immunosuppressive tumor microenvironment ...
-
based in USA
platform developed and optimized to interrogate the responses of your Immuno-Oncology drugs with a tumor-specific microenvironment in only 4 days using PDX-O (patient-derived xenograft organoids) collected with matched, autologous TIL ...
-
Manufactured by SOFIEbased in USA
Staying true to our vision to improve patient outcomes by developing and delivering molecular diagnostics and therapeutics, SOFIE has acquired global rights for the diagnostic and companion diagnostic use of the FAPI family of compounds from University of Heidelberg, the team that invented PSMA-617 (Novartis). The FAPI family of compounds have demonstrated promising theranostic ...
-
based in USA
For rapid and precise cancer care, pathologists and oncologists need dependable diagnostic testing to connect patients to individualized immuno-oncology therapies. Flagship’s TissueInsight® diagnostic service offers you access to robust, contextual data for advanced patient care. Our exclusive, targeted testing in our CAP/CLIA lab provides the most accurate and precise tissue scoring ...
-
Manufactured by MedGenome Inc.based in USA
A comprehensive suite of bioinformatics services for NGS data analysis encompassing a wide range of applications including genomics, transcriptomics, single cell genomics, immune profiling, genome assembly and annotation and more. Our team of experts combined with our advanced reporting have resulted in over 200 scientific publications in high-impact journals. Let us help you get the most out of ...
-
Manufactured by Veracytebased in FRANCE
Veracyte’s Cancer Immune Atlas allows clinical researchers to maximize the value of the data generated through our Immunogram analysis platform. The Cancer Immune Atlas creates a reference database from individual Immunograms, to generate biomarker maps, assess toxicity and drug response, stratify patients, and develop predictive ...
-
Manufactured by Kymab, a Sanofi companybased in UNITED KINGDOM
Innovative antibody-based molecular concepts. New treatments for cancer that leverage our own immune system to attack and destroy cancer cells can provide long-term and durable therapeutic responses in patients suffering from life-threatening malignancies. These benefits for patients have been driven by recently developed therapeutic antibodies binding with high specificity to drug targets on ...
-
Manufactured by Immatics N.V.based in GERMANY
ACTallo® is a process developed by Immatics for the manufacture of allogeneic, off-the-shelf, TCR-engineered cellular therapies derived from healthy donors’ gamma delta T ...
Need help finding the right suppliers? Try XPRT Sourcing. Let the XPRTs do the work for you